Industry Experts

Amit Katiyar is Senior Director, Biologics Analytical and a member of the External Manufacturing Operations organization at Exelixis, where he provides strategic leadership for analytical development and CMC execution across biologics and antibody-drug conjugate (ADC) programs. With more than 20 years of experience at Exelixis, Bristol Myers Squibb, Merck, and other leading biopharmaceutical companies, he has advanced multiple biologics from discovery through clinical development and regulatory submission. Amit is recognized for building high-performing teams, driving platform-based CMC strategies, and accelerating development timelines through innovative, risk-based approaches. He is passionate about enabling the rapid delivery of transformative therapies to patients while advancing industry best practices in biologics and ADC development.